In utero origins of adult insulin resistance and vascular dysfunction

Seminars in Reproductive Medicine

Volumn 29, Issue 3, 2011, Pages 211-224

  Thompson, Jennifer A ^a   Regnault, Timothy R H ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

adult; endothelial dysfunction; Fetus; insulin resistance; muscle; programming; vascular dysfunction; vessels

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; TRIACYLGLYCEROL;

ADULT; ARTICLE; ATHEROSCLEROSIS; BIRTH WEIGHT; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MALFORMATION; CARDIOVASCULAR RESPONSE; CELL PROLIFERATION; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; FETUS; FETUS GROWTH; HEALTH; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAUTERINE GROWTH RETARDATION; KIDNEY DEVELOPMENT; LIFESTYLE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PERINATAL PERIOD; PHENOTYPE; PLACENTA INSUFFICIENCY; PROGENY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SKELETAL MUSCLE; VASCULAR DISEASE;

ADULT; ANIMALS; BLOOD VESSELS; FEMALE; FETAL DEVELOPMENT; HUMANS; HYPERTENSION; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MUSCLE, SKELETAL; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; VASCULAR DISEASES;

EID: 79959779810     PISSN: 15268004     EISSN: 15264564     Source Type: Journal    
DOI: 10.1055/s-0031-1275522     Document Type: Article

References (185)

1. Osmond C, Barker D J. Fetal, infant, and childhood growth are predictors of coronary heart disease, diabetes, and hypertension in adult men and women. Environ Health Perspect 2000 108 Suppl 3 545-553 (Pubitemid 30466181)
2. Ross M G., Beall M H. Adult sequelae of intrauterine growth restriction. Semin Perinatol 2008 32 3 213-218 (Pubitemid 351636319)
3. Eriksson J G., Forsén T, Tuomilehto J, Winter P D., Osmond C, Barker D J. Catch-up growth in childhood and death from coronary heart disease: longitudinal study. BMJ 1999 318 7181 427-431 (Pubitemid 29192114)
4. Arends N J., Boonstra V H., Duivenvoorden H J., Hofman P L., Cutfield W S., Hokken-Koelega A C. Reduced insulin sensitivity and the presence of cardiovascular risk factors in short prepubertal children born small for gestational age (SGA). Clin Endocrinol (Oxf) 2005 62 1 44-50 (Pubitemid 40175282)
5. Barker D J., Osmond C, Forsén T J., Kajantie E, Eriksson J G. Trajectories of growth among children who have coronary events as adults. N Engl J Med 2005 353 17 1802-1809 (Pubitemid 41549892)
6. Morton J S., Rueda-Clausen C F., Davidge S T. Mechanisms of endothelium-dependent vasodilation in male and female, young and aged offspring born growth restricted. Am J Physiol Regul Integr Comp Physiol 2010 298 4 R930-R938
7. Barker D J. The developmental origins of insulin resistance. Horm Res 2005 64 Suppl 3 2-7 (Pubitemid 43163306)
8. Stary H C. Evolution and progression of atherosclerotic lesions in coronary arteries of children and young adults. Arteriosclerosis 1989 9 1, Suppl I19-I32 (Pubitemid 19046963)
9. Singhal A. Endothelial dysfunction: role in obesity-related disorders and the early origins of CVD. Proc Nutr Soc 2005 64 1 15-22 (Pubitemid 40685747)
10. Ness R B., Sibai B M. Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia. Am J Obstet Gynecol 2006 195 1 40-49 (Pubitemid 43927490)
11. Regnault T R., de Vrijer B, Galan H L., Wilkening R B., Battaglia F C., Meschia G. Development and mechanisms of fetal hypoxia in severe fetal growth restriction. Placenta 2007 28 7 714-723 (Pubitemid 46852286)
12. Mayhew T M., Manwani R, Ohadike C, Wijesekara J, Baker P N. The placenta in pre-eclampsia and intrauterine growth restriction: studies on exchange surface areas, diffusion distances and villous membrane diffusive conductances. Placenta 2006 28 3 233-238 (Pubitemid 44914525)
13. Resnik R. Intrauterine growth restriction. Obstet Gynecol 2002 99 3 490-496 (Pubitemid 34188412)
14. Marconi A M., Paolini C L., Stramare L et al. Steady state maternal-fetal leucine enrichments in normal and intrauterine growth-restricted pregnancies. Pediatr Res 1999 46 1 114-119 (Pubitemid 29293906)
15. Paolini C L., Marconi A M., Ronzoni S et al. Placental transport of leucine, phenylalanine, glycine, and proline in intrauterine growth-restricted pregnancies. J Clin Endocrinol Metab 2001 86 11 5427-5432 (Pubitemid 33070270)
16. Thureen P J., Trembler K A., Meschia G, Makowski E L., Wilkening R B. Placental glucose transport in heat-induced fetal growth retardation. Am J Physiol 1992 263 3 Pt 2 R578-R585
17. Alvino G, Cozzi V, Radaelli T, Ortega H, Herrera E, Cetin I. Maternal and fetal fatty acid profile in normal and intrauterine growth restriction pregnancies with and without preeclampsia. Pediatr Res 2008 64 6 615-620
18. Rodie V A., Caslake M J., Stewart F et al. Fetal cord plasma lipoprotein status in uncomplicated human pregnancies and in pregnancies complicated by pre-eclampsia and intrauterine growth restriction. Atherosclerosis 2004 176 1 181-187 (Pubitemid 39078661)
19. Lackman F, Capewell V, Gagnon R, Richardson B. Fetal umbilical cord oxygen values and birth to placental weight ratio in relation to size at birth. Am J Obstet Gynecol 2001 185 3 674-682 (Pubitemid 32862558)
20. Cheema R, Dubiel M, Gudmundsson S. Signs of fetal brain sparing are not related to umbilical cord blood gases at birth. Early Hum Dev 2009 85 7 467-470
21. Arbeille P. Fetal arterial Doppler-IUGR and hypoxia. Eur J Obstet Gynecol Reprod Biol 1997 75 1 51-53 (Pubitemid 28009865)
22. Baschat A A. Fetal responses to placental insufficiency: an update. BJOG 2004 111 10 1031-1041 (Pubitemid 39319260)
23. Rurak D W., Richardson B S., Patrick J E., Carmichael L, Homan J. Blood flow and oxygen delivery to fetal organs and tissues during sustained hypoxemia. Am J Physiol 1990 258 5 Pt 2 R1116-R1122 (Pubitemid 20187239)
24. Verkauskiene R, Beltrand J, Claris O et al. Impact of fetal growth restriction on body composition and hormonal status at birth in infants of small and appropriate weight for gestational age. Eur J Endocrinol 2007 157 5 605-612 (Pubitemid 350187377)
25. Widdowson E M., Crabb D E., Milner R D. Cellular development of some human organs before birth. Arch Dis Child 1972 47 254 652-655
26. Mi J, Cheng H, Zhao X Y., Hou D Q., Chen F F., Zhang K L. Developmental origin of metabolic syndrome: interaction of thinness at birth and overweight during adult life in Chinese population. Obes Rev 2008 9 Suppl 1 91-94 (Pubitemid 351643198)
27. Marconi A M., Ronzoni S, Vailati S, Bozzetti P, Morabito A, Battaglia F C. Neonatal morbidity and mortality in intrauterine growth restricted (IUGR) pregnancies is predicated upon prenatal diagnosis of clinical severity. Reprod Sci 2009 16 4 373-379
28. Ozanne S E., Constância M. Mechanisms of disease: the developmental origins of disease and the role of the epigenotype. Nat Clin Pract Endocrinol Metab 2007 3 7 539-546 (Pubitemid 46975821)
29. Gluckman P D., Hanson M A., Cooper C, Thornburg K L. Effect of in utero and early-life conditions on adult health and disease. N Engl J Med 2008 359 1 61-73
30. Rogers M S., Murray H G., Wang C C. et al. Oxidative stress in the fetal lamb brain following intermittent umbilical cord occlusion: a path analysis. BJOG 2001 108 12 1283-1290 (Pubitemid 34076741)
31. Baker J E. Oxidative stress and adaptation of the infant heart to hypoxia and ischemia. Antioxid Redox Signal 2004 6 2 423-429 (Pubitemid 38332600)
32. Grattagliano I, Palmieri V O., Portincasa P, Moschetta A, Palasciano G. Oxidative stress-induced risk factors associated with the metabolic syndrome: a unifying hypothesis. J Nutr Biochem 2008 19 8 491-504 (Pubitemid 351952322)
33. Tintu A N., Noble F A., Rouwet E V. Hypoxia disturbs fetal hemodynamics and growth. Endothelium 2007 14 6 353-360
34. Fernandez-Twinn D S., Ozanne S E. Mechanisms by which poor early growth programs type-2 diabetes, obesity and the metabolic syndrome. Physiol Behav 2006 88 3 234-243
35. Luo Z C., Fraser W D., Julien P et al. Tracing the origins of fetal origins of adult diseases: programming by oxidative stress? Med Hypotheses 2006 66 1 38-44 (Pubitemid 41605102)
36. Jensen C B., Martin-Gronert M S., Storgaard H, Madsbad S, Vaag A, Ozanne S E. Altered PI3-kinase/Akt signalling in skeletal muscle of young men with low birth weight. PLoS ONE 2008 3 11 e3738
37. Singhal A, Fewtrell M, Cole T J., Lucas A. Low nutrient intake and early growth for later insulin resistance in adolescents born preterm. Lancet 2003 361 9363 1089-1097 (Pubitemid 36369562)
38. Phillips D I. Insulin resistance as a programmed response to fetal undernutrition. Diabetologia 1996 39 9 1119-1122 (Pubitemid 26275944)
39. Jaquet D, Deghmoun S, Chevenne D, Collin D, Czernichow P, Lévy-Marchal C. Dynamic change in adiposity from fetal to postnatal life is involved in the metabolic syndrome associated with reduced fetal growth. Diabetologia 2005 48 5 849-855 (Pubitemid 40767976)
40. Eriksson J G., Forsén T, Tuomilehto J, Jaddoe V W., Osmond C, Barker D J. Effects of size at birth and childhood growth on the insulin resistance syndrome in elderly individuals. Diabetologia 2002 45 3 342-348 (Pubitemid 34267356)
41. Jaquet D, Gaboriau A, Czernichow P, Levy-Marchal C. Insulin resistance early in adulthood in subjects born with intrauterine growth retardation. J Clin Endocrinol Metab 2000 85 4 1401-1406 (Pubitemid 32289480)
42. Hofman P L., Cutfield W S., Robinson E M. et al. Insulin resistance in short children with intrauterine growth retardation. J Clin Endocrinol Metab 1997 82 2 402-406 (Pubitemid 27068600)
43. Karlberg J P., Albertsson-Wikland K, Kwan E Y., Lam B C., Low L C. The timing of early postnatal catch-up growth in normal, full-term infants born short for gestational age. Horm Res 1997 48 Suppl 1 17-24 (Pubitemid 27199178)
44. Louey S, Cock M L., Harding R. Long term consequences of low birthweight on postnatal growth, adiposity and brain weight at maturity in sheep. J Reprod Dev 2005 51 1 59-68 (Pubitemid 41359862)
45. Cosmi E, Visentin S, Fanelli T, Mautone A J., Zanardo V. Aortic intima media thickness in fetuses and children with intrauterine growth restriction. Obstet Gynecol 2009 114 5 1109-1114
46. Contreras C, Sánchez A, Martínez P et al. Insulin resistance in penile arteries from a rat model of metabolic syndrome. Br J Pharmacol 2010 161 2 350-364
47. Cunningham J T., Rodgers J T., Arlow D H., Vazquez F, Mootha V K., Puigserver P. mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex. Nature 2007 450 7170 736-740 (Pubitemid 350207689)
48. Dressel U, Allen T L., Pippal J B., Rohde P R., Lau P, Muscat G E. The peroxisome proliferator-activated receptor beta/delta agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells. Mol Endocrinol 2003 17 12 2477-2493 (Pubitemid 37542211)
49. Schuler M, Ali F, Chambon C et al. PGC1alpha expression is controlled in skeletal muscles by PPARbeta, whose ablation results in fiber-type switching, obesity, and type 2 diabetes. Cell Metab 2006 4 5 407-414 (Pubitemid 44645068)
50. Krämer D K., Ahlsén M, Norrbom J et al. Human skeletal muscle fibre type variations correlate with PPAR alpha, PPAR delta and PGC-1 alpha mRNA. Acta Physiol (Oxf) 2006 188 34 207-216 (Pubitemid 44622368)
51. Loviscach M, Rehman N, Carter L et al. Distribution of peroxisome proliferator-activated receptors (PPARs) in human skeletal muscle and adipose tissue: relation to insulin action. Diabetologia 2000 43 3 304-311 (Pubitemid 30163473)
52. Handel S E., Stickland N C. The effects of low birthweight on the ultrastructural development of two myofibre types in the pig. J Anat 1987 150 129-143 (Pubitemid 17020211)
53. Picard B, Lefaucheur L, Berri C, Duclos M J. Muscle fibre ontogenesis in farm animal species. Reprod Nutr Dev 2002 42 5 415-431 (Pubitemid 36113384)
54. He J, Watkins S, Kelley D E. Skeletal muscle lipid content and oxidative enzyme activity in relation to muscle fiber type in type 2 diabetes and obesity. Diabetes 2001 50 4 817-823 (Pubitemid 32242639)
55. Fahey A J., Brameld J M., Parr T, Buttery P J. Ontogeny of factors associated with proliferation and differentiation of muscle in the ovine fetus. J Anim Sci 2005 83 10 2330-2338
56. McCoard S A., McNabb W C., Peterson S W., McCutcheon S N., Harris P M. Muscle growth, cell number, type and morphometry in single and twin fetal lambs during mid to late gestation. Reprod Fertil Dev 2000 12 56 319-327 (Pubitemid 32514762)
57. Tilley R E., McNeil C J., Ashworth C J., Page K R., Mcardle H J. Altered muscle development and expression of the insulin-like growth factor system in growth retarded fetal pigs. Domest Anim Endocrinol 2007 32 3 167-177 (Pubitemid 46241787)
58. Rees W D., Hay S M., Cruickshank M et al. Maternal protein intake in the pregnant rat programs the insulin axis and body composition in the offspring. Metabolism 2006 55 5 642-649
59. Nyholm B, Qu Z, Kaal A et al. Evidence of an increased number of type IIb muscle fibers in insulin-resistant first-degree relatives of patients with NIDDM. Diabetes 1997 46 11 1822-1828 (Pubitemid 27456417)
60. Lagouge M, Argmann C, Gerhart-Hines Z et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 2006 127 6 1109-1122 (Pubitemid 44894520)
61. Malenfant P, Joanisse D R., Thériault R, Goodpaster B H., Kelley D E., Simoneau J A. Fat content in individual muscle fibers of lean and obese subjects. Int J Obes Relat Metab Disord 2001 25 9 1316-1321 (Pubitemid 32835448)
62. Zhu M J., Ford S P., Means W J., Hess B W., Nathanielsz P W., Du M. Maternal nutrient restriction affects properties of skeletal muscle in offspring. J Physiol 2006 575 Pt 1 241-250 (Pubitemid 44178141)
63. DeFronzo R A. Pathogenesis of type 2 (non-insulin dependent) diabetes mellitus: a balanced overview. Diabetologia 1992 35 4 389-397
64. Taniguchi C M., Emanuelli B, Kahn C R. Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol 2006 7 2 85-96 (Pubitemid 43278292)
65. Fingar D C., Richardson C J., Tee A R., Cheatham L, Tsou C, Blenis J. mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E. Mol Cell Biol 2004 24 1 200-216 (Pubitemid 38010048)
66. Thorn S R., Regnault T R., Brown L D. et al. Intrauterine growth restriction increases fetal hepatic gluconeogenic capacity and reduces messenger ribonucleic acid translation initiation and nutrient sensing in fetal liver and skeletal muscle. Endocrinology 2009 150 7 3021-3030
67. Muhlhausler B S., Duffield J A., Ozanne S E. et al. The transition from fetal growth restriction to accelerated postnatal growth: a potential role for insulin signalling in skeletal muscle. J Physiol 2009 587 Pt 17 4199-4211
68. Fahey A J., Brameld J M., Parr T, Buttery P J. The effect of maternal undernutrition before muscle differentiation on the muscle fiber development of the newborn lamb. J Anim Sci 2005 83 11 2564-2571
69. Zhu M J., Ford S P., Nathanielsz P W., Du M. Effect of maternal nutrient restriction in sheep on the development of fetal skeletal muscle. Biol Reprod 2004 71 6 1968-1973 (Pubitemid 39586944)
70. Basu A, Lenka N, Mullick J, Avadhani N G. Regulation of murine cytochrome oxidase Vb gene expression in different tissues and during myogenesis. Role of a YY-1 factor-binding negative enhancer. J Biol Chem 1997 272 9 5899-5908 (Pubitemid 27102425)
71. Schieke S M., Phillips D, McCoy J P. Jr et al. The mammalian target of rapamycin (mTOR) pathway regulates mitochondrial oxygen consumption and oxidative capacity. J Biol Chem 2006 281 37 27643-27652 (Pubitemid 44401789)
72. Selak M A., Storey B T., Peterside I, Simmons R A. Impaired oxidative phosphorylation in skeletal muscle of intrauterine growth-retarded rats. Am J Physiol Endocrinol Metab 2003 285 1 E130-E137 (Pubitemid 36736370)
73. Thamer C, Stumvoll M, Niess A et al. Reduced skeletal muscle oxygen uptake and reduced beta-cell function: two early abnormalities in normal glucose-tolerant offspring of patients with type 2 diabetes. Diabetes Care 2003 26 7 2126-2132 (Pubitemid 41184263)
74. Dressel U, Allen T L., Pippal J B., Rohde P R., Lau P, Muscat G E. The peroxisome proliferator-activated receptor beta/delta agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells. Mol Endocrinol 2003 17 12 2477-2493 (Pubitemid 37542211)
75. Lin J, Wu H, Tarr P T. et al. Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature 2002 418 6899 797-801
76. Benton C R., Nickerson J G., Lally J et al. Modest PGC-1alpha overexpression in muscle in vivo is sufficient to increase insulin sensitivity and palmitate oxidation in subsarcolemmal, not intermyofibrillar, mitochondria. J Biol Chem 2008 283 7 4228-4240
77. Mensink M, Hesselink M K., Russell A P., Schaart G, Sels J P., Schrauwen P. Improved skeletal muscle oxidative enzyme activity and restoration of PGC-1 alpha and PPAR beta/delta gene expression upon rosiglitazone treatment in obese patients with type 2 diabetes mellitus. Int J Obes (Lond) 2007 31 8 1302-1310 (Pubitemid 47172612)
78. Patti M E., Butte A J., Crunkhorn S et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc Natl Acad Sci U S A 2003 100 14 8466-8471 (Pubitemid 36842568)
79. Lane R H., MacLennan N K., Hsu J L., Janke S M., Pham T D. Increased hepatic peroxisome proliferator-activated receptor-gamma coactivator-1 gene expression in a rat model of intrauterine growth retardation and subsequent insulin resistance. Endocrinology 2002 143 7 2486-2490 (Pubitemid 34701309)
80. Jucker B M., Yang D, Casey W M. et al. Selective PPARdelta agonist treatment increases skeletal muscle lipid metabolism without altering mitochondrial energy coupling: an in vivo magnetic resonance spectroscopy study. Am J Physiol Endocrinol Metab 2007 293 5 E1256-E1264 (Pubitemid 350106592)
81. Koopman R, Schaart G, Hesselink M K. Optimisation of oil red O staining permits combination with immunofluorescence and automated quantification of lipids. Histochem Cell Biol 2001 116 1 63-68 (Pubitemid 32695819)
82. Brunmair B, Staniek K, Dörig J et al. Activation of PPAR-delta in isolated rat skeletal muscle switches fuel preference from glucose to fatty acids. Diabetologia 2006 49 11 2713-2722
83. Young M E., Patil S, Ying J et al. Uncoupling protein 3 transcription is regulated by peroxisome proliferator-activated receptor (alpha) in the adult rodent heart. FASEB J 2001 15 3 833-845 (Pubitemid 32246002)
84. Vettor R, Lombardi A M., Fabris R et al. Lactate infusion in anesthetized rats produces insulin resistance in heart and skeletal muscles. Metabolism 1997 46 6 684-690 (Pubitemid 27247305)
85. Sugden M C., Caton P W., Holness M J. PPAR control: it's SIRTainly as easy as PGC. J Endocrinol 2010 204 2 93-104
86. de Lange P, Moreno M, Silvestri E, Lombardi A, Goglia F, Lanni A. Fuel economy in food-deprived skeletal muscle: signaling pathways and regulatory mechanisms. FASEB J 2007 21 13 3431-3441 (Pubitemid 350075134)
87. Gerhart-Hines Z, Rodgers J T., Bare O et al. Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1alpha. EMBO J 2007 26 7 1913-1923 (Pubitemid 46624046)
88. Rodgers J T., Lerin C, Haas W, Gygi S P., Spiegelman B M., Puigserver P. Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 2005 434 7029 113-118 (Pubitemid 40349395)
89. Baur J A., Pearson K J., Price N L. et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006 444 7117 337-342 (Pubitemid 44764104)
90. Wu X, Chang M S., Mitsialis S A., Kourembanas S. Hypoxia regulates bone morphogenetic protein signaling through C-terminal-binding protein 1. Circ Res 2006 99 3 240-247 (Pubitemid 44174931)
91. Zhang Q, Wang S Y., Nottke A C., Rocheleau J V., Piston D W., Goodman R H. Redox sensor CtBP mediates hypoxia-induced tumor cell migration. Proc Natl Acad Sci U S A 2006 103 24 9029-9033 (Pubitemid 43902527)
92. Zhang Q, Wang S Y., Fleuriel C et al. Metabolic regulation of SIRT1 transcription via a HIC1:CtBP corepressor complex. Proc Natl Acad Sci U S A 2007 104 3 829-833 (Pubitemid 46154696)
93. Ido Y. Pyridine nucleotide redox abnormalities in diabetes. Antioxid Redox Signal 2007 9 7 931-942 (Pubitemid 46919594)
94. Regnault T R., Zhao L, Chiu J S., Gottheil S K., Foran A, Yee S. Peroxisome Proliferator-activated receptor -/, - agonists and resveratrol modulate hypoxia induced changes in nuclear receptor activators of muscle oxidative metabolism. PPAR Res 2010 2010 129173
95. Lane R H., Chandorkar A K., Flozak A S., Simmons R A. Intrauterine growth retardation alters mitochondrial gene expression and function in fetal and juvenile rat skeletal muscle. Pediatr Res 1998 43 5 563-570 (Pubitemid 28196445)
96. Brøns C, Jensen C B., Storgaard H et al. Mitochondrial function in skeletal muscle is normal and unrelated to insulin action in young men born with low birth weight. J Clin Endocrinol Metab 2008 93 10 3885-3892
97. Szendroedi J, Schmid A I., Chmelik M et al. Muscle mitochondrial ATP synthesis and glucose transport/phosphorylation in type 2 diabetes. PLoS Med 2007 4 5 e154
98. Kliewer S A., Xu H E., Lambert M H., Willson T M. Peroxisome proliferator-activated receptors: from genes to physiology. Recent Prog Horm Res 2001 56 239-263
99. Macdonald N, Holden P R., Roberts R A. Addition of peroxisome proliferator-activated receptor alpha to guinea pig hepatocytes confers increased responsiveness to peroxisome proliferators. Cancer Res 1999 59 19 4776-4780 (Pubitemid 29472874)
100. Bonen A, Holloway G P., Tandon N N. et al. Cardiac and skeletal muscle fatty acid transport and transporters and triacylglycerol and fatty acid oxidation in lean and Zucker diabetic fatty rats. Am J Physiol Regul Integr Comp Physiol 2009 297 4 R1202-R1212
101. Holloway G P., Benton C R., Mullen K L. et al. In obese rat muscle transport of palmitate is increased and is channeled to triacylglycerol storage despite an increase in mitochondrial palmitate oxidation. Am J Physiol Endocrinol Metab 2009 296 4 E738-E747
102. Holst D, Luquet S, Nogueira V, Kristiansen K, Leverve X, Grimaldi P A. Nutritional regulation and role of peroxisome proliferator-activated receptor delta in fatty acid catabolism in skeletal muscle. Biochim Biophys Acta 2003 1633 1 43-50 (Pubitemid 36773945)
103. Chevillotte E, Rieusset J, Roques M, Desage M, Vidal H. The regulation of uncoupling protein-2 gene expression by omega-6 polyunsaturated fatty acids in human skeletal muscle cells involves multiple pathways, including the nuclear receptor peroxisome proliferator-activated receptor beta. J Biol Chem 2001 276 14 10853-10860 (Pubitemid 38089262)
104. Bezaire V, Spriet L L., Campbell S et al. Constitutive UCP3 overexpression at physiological levels increases mouse skeletal muscle capacity for fatty acid transport and oxidation. FASEB J 2005 19 8 977-979 (Pubitemid 40827723)
105. Brand M D., Pamplona R, Portero-Otín M et al. Oxidative damage and phospholipid fatty acyl composition in skeletal muscle mitochondria from mice underexpressing or overexpressing uncoupling protein 3. Biochem J 2002 368 Pt 2 597-603 (Pubitemid 35454538)
106. Brandt J M., Djouadi F, Kelly D P. Fatty acids activate transcription of the muscle carnitine palmitoyltransferase I gene in cardiac myocytes via the peroxisome proliferator-activated receptor alpha. J Biol Chem 1998 273 37 23786-23792 (Pubitemid 28435712)
107. Hulver M W., Dohm G L. The molecular mechanism linking muscle fat accumulation to insulin resistance. Proc Nutr Soc 2004 63 2 375-380 (Pubitemid 38787493)
108. Luquet S, Lopez-Soriano J, Holst D et al. Peroxisome proliferator- activated receptor delta controls muscle development and oxidative capability. FASEB J 2003 17 15 2299-2301 (Pubitemid 39561472)
109. Barak Y, Liao D, He W et al. Effects of peroxisome proliferator-activated receptor delta on placentation, adiposity, and colorectal cancer. Proc Natl Acad Sci U S A 2002 99 1 303-308 (Pubitemid 34060358)
110. Wang Y X., Lee C H., Tiep S et al. Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity. Cell 2003 113 2 159-170 (Pubitemid 36514968)
111. Wang Y X., Zhang C L., Yu R T. et al. Regulation of muscle fiber type and running endurance by PPARdelta. PLoS Biol 2004 2 10 e294
112. Magee T R., Han G, Cherian B, Khorram O, Ross M G., Desai M. Down-regulation of transcription factor peroxisome proliferator-activated receptor in programmed hepatic lipid dysregulation and inflammation in intrauterine growth-restricted offspring. Am J Obstet Gynecol 2008 199 3 271-275, e1e5
113. Burdge G C., Slater-Jefferies J, Torrens C, Phillips E S., Hanson M A., Lillycrop K A. Dietary protein restriction of pregnant rats in the F0 generation induces altered methylation of hepatic gene promoters in the adult male offspring in the F1 and F2 generations. Br J Nutr 2007 97 3 435-439 (Pubitemid 46662031)
114. Kind K L., Simonetta G, Clifton P M., Robinson J S., Owens J A. Effect of maternal feed restriction on blood pressure in the adult guinea pig. Exp Physiol 2002 87 4 469-477 (Pubitemid 34814575)
115. Kind K L., Clifton P M., Grant P A. et al. Effect of maternal feed restriction during pregnancy on glucose tolerance in the adult guinea pig. Am J Physiol Regul Integr Comp Physiol 2003 284 1 R140-R152 (Pubitemid 36008665)
116. Lillycrop K A., Phillips E S., Jackson A A., Hanson M A., Burdge G C. Dietary protein restriction of pregnant rats induces and folic acid supplementation prevents epigenetic modification of hepatic gene expression in the offspring. J Nutr 2005 135 6 1382-1386 (Pubitemid 40799599)
117. Boney C M., Verma A, Tucker R, Vohr B R. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics 2005 115 3 e290-e296 (Pubitemid 43373011)
118. Gluckman P D., Hanson M A. Metabolic disease: evolutionary, developmental and transgenerational influences. In: Hornstra G Uauy R Yang X eds. The Impact of Maternal Nutrition on the Offspring. Basel, Switzerland Vevey/S. Karger 2005 17-27
119. Simmons R. Developmental origins of adult metabolic disease: concepts and controversies. Trends Endocrinol Metab 2005 16 8 390-394 (Pubitemid 41338745)
120. Barker D J., Hales C N., Fall C H., Osmond C, Phipps K, Clark P M. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 1993 36 1 62-67 (Pubitemid 23018337)
121. Barker D J. Fetal programming of coronary heart disease. Trends Endocrinol Metab 2002 13 9 364-368 (Pubitemid 36723587)
122. Bertram C E., Hanson M A. Animal models and programming of the metabolic syndrome. Br Med Bull 2001 60 103-121 (Pubitemid 34123507)
123. De Blasio M J., Gatford K L., McMillen I C., Robinson J S., Owens J A. Placental restriction of fetal growth increases insulin action, growth, and adiposity in the young lamb. Endocrinology 2007 148 3 1350-1358
124. Jaquet D, Vidal H, Hankard R, Czernichow P, Levy-Marchal C. Impaired regulation of glucose transporter 4 gene expression in insulin resistance associated with in utero undernutrition. J Clin Endocrinol Metab 2001 86 7 3266-3271 (Pubitemid 32673496)
125. Ozanne S E., Olsen G S., Hansen L L. et al. Early growth restriction leads to down regulation of protein kinase C zeta and insulin resistance in skeletal muscle. J Endocrinol 2003 177 2 235-241 (Pubitemid 36656396)
126. Sparks L M., Xie H, Koza R A. et al. A high-fat diet coordinately downregulates genes required for mitochondrial oxidative phosphorylation in skeletal muscle. Diabetes 2005 54 7 1926-1933 (Pubitemid 40911253)
127. Coll T, Jové M, Rodríguez-Calvo R et al. Palmitate-mediated downregulation of peroxisome proliferator-activated receptor-gamma coactivator 1alpha in skeletal muscle cells involves MEK1/2 and nuclear factor-kappaB activation. Diabetes 2006 55 10 2779-2787 (Pubitemid 44923677)
128. Hoeks J, Hesselink M K., Russell A P. et al. Peroxisome proliferator-activated receptor-gamma coactivator-1 and insulin resistance: acute effect of fatty acids. Diabetologia 2006 49 10 2419-2426 (Pubitemid 44359104)
129. Staiger H, Staiger K, Haas C, Weisser M, Machicao F, Häring H U. Fatty acid-induced differential regulation of the genes encoding peroxisome proliferator-activated receptor-gamma coactivator-1alpha and -1beta in human skeletal muscle cells that have been differentiated in vitro. Diabetologia 2005 48 10 2115-2118 (Pubitemid 41416924)
130. Bayol S A., Simbi B H., Stickland N C. A maternal cafeteria diet during gestation and lactation promotes adiposity and impairs skeletal muscle development and metabolism in rat offspring at weaning. J Physiol 2005 567 Pt 3 951-961 (Pubitemid 41387836)
131. Schaiff W T., Knapp F F. Jr, Barak Y, Biron-Shental T, Nelson D M., Sadovsky Y. Ligand-activated peroxisome proliferator activated receptor gamma alters placental morphology and placental fatty acid uptake in mice. Endocrinology 2007 148 8 3625-3634 (Pubitemid 47105868)
132. Schaiff W T., Bildirici I, Cheong M, Chern P L., Nelson D M., Sadovsky Y. Peroxisome proliferator-activated receptor-gamma and retinoid X receptor signaling regulate fatty acid uptake by primary human placental trophoblasts. J Clin Endocrinol Metab 2005 90 7 4267-4275 (Pubitemid 41058208)
133. Garg M, Thamotharan M, Oak S A. et al. Early exercise regimen improves insulin sensitivity in the intrauterine growth-restricted adult female rat offspring. Am J Physiol Endocrinol Metab 2009 296 2 E272-E281
134. Eriksson J G., Ylihärsilä H, Forsén T, Osmond C, Barker D J. Exercise protects against glucose intolerance in individuals with a small body size at birth. Prev Med 2004 39 1 164-167 (Pubitemid 38797968)
135. Koves T R., Ussher J R., Noland R C. et al. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab 2008 7 1 45-56
136. Kim J Y., Hickner R C., Cortright R L., Dohm G L., Houmard J A. Lipid oxidation is reduced in obese human skeletal muscle. Am J Physiol Endocrinol Metab 2000 279 5 E1039-E1044
137. Simoneau J A., Veerkamp J H., Turcotte L P., Kelley D E. Markers of capacity to utilize fatty acids in human skeletal muscle: relation to insulin resistance and obesity and effects of weight loss. FASEB J 1999 13 14 2051-2060 (Pubitemid 29517635)
138. Godfrey K M., Lillycrop K A., Burdge G C., Gluckman P D., Hanson M A. Epigenetic mechanisms and the mismatch concept of the developmental origins of health and disease. Pediatr Res 2007 61 5 Pt 2 5R-10R (Pubitemid 46653061)
139. Evans R M., Barish G D., Wang Y X. PPARs and the complex journey to obesity. Nat Med 2004 10 4 355-361 (Pubitemid 38508511)
140. Kumar N, Dey C S. Development of insulin resistance and reversal by thiazolidinediones in C2C12 skeletal muscle cells. Biochem Pharmacol 2003 65 2 249-257 (Pubitemid 36015827)
141. Kim J E., Chen J. regulation of peroxisome proliferator-activated receptor-gamma activity by mammalian target of rapamycin and amino acids in adipogenesis. Diabetes 2004 53 11 2748-2756 (Pubitemid 39425899)
142. Benton C R., Holloway G P., Campbell S E. et al. Rosiglitazone increases fatty acid oxidation and fatty acid translocase (FAT/CD36) but not carnitine palmitoyltransferase I in rat muscle mitochondria. J Physiol 2008 586 6 1755-1766 (Pubitemid 351404973)
143. Luquet S, Lopez-Soriano J, Holst D et al. Roles of peroxisome proliferator-activated receptor delta (PPARdelta) in the control of fatty acid catabolism. A new target for the treatment of metabolic syndrome. Biochimie 2004 86 11 833-837 (Pubitemid 39602763)
144. Luquet S, Lopez-Soriano J, Holst D et al. Roles of peroxisome proliferator-activated receptor delta (PPARdelta) in the control of fatty acid catabolism. A new target for the treatment of metabolic syndrome. Biochimie 2004 86 11 833-837 (Pubitemid 39602763)
145. Fiévet C, Fruchart J C., Staels B. PPARalpha and PPARgamma dual agonists for the treatment of type 2 diabetes and the metabolic syndrome. Curr Opin Pharmacol 2006 6 6 606-614 (Pubitemid 44660945)
146. Grimaldi P A. Regulatory role of peroxisome proliferator-activated receptor delta (PPAR delta) in muscle metabolism. A new target for metabolic syndrome treatment? Biochimie 2005 87 1 5-8 (Pubitemid 40298758)
147. Takahashi S, Tanaka T, Kodama T, Sakai J. Peroxisome proliferator- activated receptor delta (PPARdelta), a novel target site for drug discovery in metabolic syndrome. Pharmacol Res 2006 53 6 501-507 (Pubitemid 43767554)
148. Sprecher D L., Massien C, Pearce G et al. Triglyceride:high-density lipoprotein cholesterol effects in healthy subjects administered a peroxisome proliferator activated receptor delta agonist. Arterioscler Thromb Vasc Biol 2007 27 2 359-365 (Pubitemid 46143052)
149. Howitz K T., Bitterman K J., Cohen H Y. et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 2003 425 6954 191-196 (Pubitemid 37150899)
150. Sakkinen P A., Wahl P, Cushman M, Lewis M R., Tracy R P. Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome. Am J Epidemiol 2000 152 10 897-907
151. Law C M., Shiell A W. Is blood pressure inversely related to birth weight? The strength of evidence from a systematic review of the literature. J Hypertens 1996 14 8 935-941 (Pubitemid 26306057)
152. Curhan G C., Willett W C., Rimm E B., Spiegelman D, Ascherio A L., Stampfer M J. Birth weight and adult hypertension, diabetes mellitus, and obesity in US men. Circulation 1996 94 12 3246-3250 (Pubitemid 26427494)
153. Nilsson P M., Ostergren P O., Nyberg P, Söderström M, Allebeck P. Low birth weight is associated with elevated systolic blood pressure in adolescence: a prospective study of a birth cohort of 149378 Swedish boys. J Hypertens 1997 15 12 Pt 2 1627-1631 (Pubitemid 28029656)
154. Huxley R R., Shiell A W., Law C M. The role of size at birth and postnatal catch-up growth in determining systolic blood pressure: a systematic review of the literature. J Hypertens 2000 18 7 815-831 (Pubitemid 30459482)
155. Grigore D, Ojeda N B., Robertson E B. et al. Placental insufficiency results in temporal alterations in the renin angiotensin system in male hypertensive growth restricted offspring. Am J Physiol Regul Integr Comp Physiol 2007 293 2 R804-R811 (Pubitemid 47205066)
156. Alexander B T. Placental insufficiency leads to development of hypertension in growth-restricted offspring. Hypertension 2003 41 3 457-462 (Pubitemid 36314616)
157. Wlodek M E., Westcott K, Siebel A L., Owens J A., Moritz K M. Growth restriction before or after birth reduces nephron number and increases blood pressure in male rats. Kidney Int 2008 74 2 187-195 (Pubitemid 351915084)
158. Verma S, Anderson T J. Fundamentals of endothelial function for the clinical cardiologist. Circulation 2002 105 5 546-549 (Pubitemid 34123425)
159. Celermajer D S., Sorensen K E., Bull C, Robinson J, Deanfield J E. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol 1994 24 6 1468-1474 (Pubitemid 24344241)
160. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher A M. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 1999 399 6736 601-605
161. Montagnani M, Golovchenko I, Kim I et al. Inhibition of phosphatidylinositol 3-kinase enhances mitogenic actions of insulin in endothelial cells. J Biol Chem 2002 277 3 1794-1799 (Pubitemid 34968751)
162. Musicki B, Liu T, Lagoda G A. et al. Hypercholesterolemia-induced erectile dysfunction: endothelial nitric oxide synthase (eNOS) uncoupling in the mouse penis by NAD(P)H oxidase. J Sex Med 2010 7 9 3023-3032
163. Li H, Li H, Bao Y, Zhang X, Yu Y. Free fatty acids induce endothelial dysfunction and activate protein kinase C and nuclear factor-kappaB pathway in rat aorta. Int J Cardiol 2010 August 5 (Epub ahead of print)
164. Goodfellow J, Bellamy M F., Gorman S T. et al. Endothelial function is impaired in fit young adults of low birth weight. Cardiovasc Res 1998 40 3 600-606 (Pubitemid 28557302)
165. Leeson C P., Kattenhorn M, Morley R, Lucas A, Deanfield J E. Impact of low birth weight and cardiovascular risk factors on endothelial function in early adult life. Circulation 2001 103 9 1264-1268 (Pubitemid 32221350)
166. Martin H, Hu J, Gennser G, Norman M. Impaired endothelial function and increased carotid stiffness in 9-year-old children with low birthweight. Circulation 2000 102 22 2739-2744
167. Leeson C P., Whincup P H., Cook D G. et al. Flow-mediated dilation in 9- to 11-year-old children: the influence of intrauterine and childhood factors. Circulation 1997 96 7 2233-2238 (Pubitemid 27425828)
168. Payne J A., Alexander B T., Khalil R A. Reduced endothelial vascular relaxation in growth-restricted offspring of pregnant rats with reduced uterine perfusion. Hypertension 2003 42 4 768-774 (Pubitemid 37237323)
169. Berliner J A., Heinecke J W. The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med 1996 20 5 707-727 (Pubitemid 26105783)
170. Huang K, Zou C C., Yang X Z., Chen X Q., Liang L. Carotid intima-media thickness and serum endothelial marker levels in obese children with metabolic syndrome. Arch Pediatr Adolesc Med 2010 164 9 846-851
171. Redon J, Cifkova R, Laurent S et al. Mechanisms of hypertension in the cardiometabolic syndrome. J Hypertens 2009 27 3 441-451
172. Oren A, Vos L E., Uiterwaal C S., Gorissen W H., Grobbee D E., Bots M L. Birth weight and carotid intima-media thickness: new perspectives from the atherosclerosis risk in young adults (ARYA) study. Ann Epidemiol 2004 14 1 8-16 (Pubitemid 37510044)
173. Koklu E, Kurtoglu S, Akcakus M et al. Increased aortic intima-media thickness is related to lipid profile in newborns with intrauterine growth restriction. Horm Res 2006 65 6 269-275 (Pubitemid 43876729)
174. Koklu E, Ozturk M A., Kurtoglu S, Akcakus M, Yikilmaz A, Gunes T. Aortic intima-media thickness, serum IGF-I, IGFBP-3, and leptin levels in intrauterine growth-restricted newborns of healthy mothers. Pediatr Res 2007 62 6 704-709 (Pubitemid 350158810)
175. Morgan D A., Rahmouni K. Differential effects of insulin on sympathetic nerve activity in agouti obese mice. J Hypertens 2010 28 9 1913-1919
176. Lambert G W., Straznicky N E., Lambert E A., Dixon J B., Schlaich M P. Sympathetic nervous activation in obesity and the metabolic syndromecauses, consequences and therapeutic implications. Pharmacol Ther 2010 126 2 159-172
177. Jansson T, Lambert G W. Effect of intrauterine growth restriction on blood pressure, glucose tolerance and sympathetic nervous system activity in the rat at 3-4 months of age. J Hypertens 1999 17 9 1239-1248 (Pubitemid 29509501)
178. Ojeda N B., Royals T P., Black J T., Dasinger J H., Johnson J M., Alexander B T. Enhanced sensitivity to acute angiotensin II is testosterone dependent in adult male growth-restricted offspring. Am J Physiol Regul Integr Comp Physiol 2010 298 5 R1421-R1427
179. Grigore D, Ojeda N B., Robertson E B. et al. Placental insufficiency results in temporal alterations in the renin angiotensin system in male hypertensive growth restricted offspring. Am J Physiol Regul Integr Comp Physiol 2007 293 2 R804-R811 (Pubitemid 47205066)
180. Konje J C., Okaro C I., Bell S C., de Chazal R, Taylor D J. A cross-sectional study of changes in fetal renal size with gestation in appropriate- and small-for-gestational-age fetuses. Ultrasound Obstet Gynecol 1997 10 1 22-26 (Pubitemid 27375934)
181. Spencer J, Wang Z, Hoy W. Low birth weight and reduced renal volume in Aboriginal children. Am J Kidney Dis 2001 37 5 915-920 (Pubitemid 32436562)
182. Hinchliffe S A., Lynch M R., Sargent P H., Howard C V., Van Velzen D. The effect of intrauterine growth retardation on the development of renal nephrons. Br J Obstet Gynaecol 1992 99 4 296-301
183. Moritz K M., Mazzuca M Q., Siebel A L. et al. Uteroplacental insufficiency causes a nephron deficit, modest renal insufficiency but no hypertension with ageing in female rats. J Physiol 2009 587 Pt 11 2635-2646
184. Martin J A., Osterman M J., Sutton P D. Are preterm births on the decline in the United States? Recent data from the National Vital Statistics System. NCHS Data Brief 2010 39 1-8
185. Martin J A., Hamilton B E., Sutton P D. et al, Centers for Disease Control and Prevention National Center for Health Statistics National Vital Statistics System. Births: final data for 2005. Natl Vital Stat Rep 2007 56 6 1-103